Literature DB >> 6849802

Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice.

N Brünner, M Spang-Thomsen, L Vindeløv, A Nielsen.   

Abstract

The effect of 17 beta-oestradiol on a "receptor positive" and on a "receptor negative" human breast carcinoma grown in nude mice was studied. Experimental growth data were used to determine the effect on tumour growth. Flow cytometric DNA analysis (FCM) performed on tumour tissue obtained by sequential fine-needle aspirations was used to estimate the effect on the cell cycle. In the receptor-positive breast carcinoma, oestradiol induced complete tumour regression and characteristic cell cycle changes. In the receptor-negative breast carcinoma, no changes in tumour growth and cell cycle distribution could be demonstrated following the treatment. The results indicate that the oestradiol-induced cell kill could be explained to some extent by the induction of polyploid cells, which eventually die. Since the cell cycle changes monitored by FCM in the receptor-positive breast carcinoma appeared prior to any reduction in the tumour size, the results suggest that FCM may prove a valuable method in the early detection of tumour response to hormone treatment in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849802      PMCID: PMC2011400          DOI: 10.1038/bjc.1983.102

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Radioimmunoassay of oestrone and oestradiol in human plasma.

Authors:  Y Emment; W P Collins
Journal:  Acta Endocrinol (Copenh)       Date:  1972-03

2.  Kinetic response of cultured Chinese hamster cells to treatment with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.

Authors:  R A Tobey; L L Deaven; M S Oka
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

3.  Histologic changes following oestradiol treatment of a hormone-responsive human breast carcinoma grown in nude mice.

Authors:  N Brünner; J Visfeldt
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-09

4.  Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.

Authors:  R R Weichselbaum; S Hellman; A J Piro; J J Nove; J B Little
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

5.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

6.  The variability of estrogen receptors in metastatic breast cancer.

Authors:  M J Brennan; W L Donegan; D E Appleby
Journal:  Am J Surg       Date:  1979-02       Impact factor: 2.565

7.  Growth curves of three human malignant tumors transplanted to nude mice.

Authors:  M Spang-Thomsen; A Nielsen; J Visfeldt
Journal:  Exp Cell Biol       Date:  1980

8.  3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.

Authors:  B Nordenskjöld; T Löwhagen; H Westerberg; J Zajicek
Journal:  Acta Cytol       Date:  1976 Mar-Apr       Impact factor: 2.319

9.  Estrogen receptor levels in multiple biopsies from patients with breast cancer.

Authors:  D J Webster; D G Bronn; J P Minton
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

10.  Heterogeneous response of disseminated human ovarian cancers to cytostatics in vitro.

Authors:  C Tropé; K Aspegren; S Kullander; B Astedt
Journal:  Acta Obstet Gynecol Scand       Date:  1979       Impact factor: 3.636

View more
  9 in total

Review 1.  Endocrine therapy of human breast cancer grown in nude mice.

Authors:  N Brünner; C K Osborne; M Spang-Thomsen
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

2.  The effects of estrogen on human breast carcinomas serially transplanted into nude mice.

Authors:  T Fukutomi; K Yamaguchi; T Kubota; T Ikeda; K Enomoto; K Ishibiki; O Abe
Journal:  Jpn J Surg       Date:  1989-11

3.  Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis.

Authors:  V Craig Jordan; Leslie G Ford
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-10

Review 4.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

5.  DNA flow cytometric study of 5-fluorouracil used to treat end stage non-Hodgkin's lymphoma.

Authors:  D W Hedley
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

6.  In vitro sensitivity test of breast cancer cells to hormonal agents in a radionucleotide-incorporation assay.

Authors:  T Watanabe; J Z Wu; K Morikawa; M Fuchigami; M Kuranami; I Adachi; K Yamaguchi; K Abe
Journal:  Jpn J Cancer Res       Date:  1990-05

7.  Disaggregation of human solid tumours by combined mechanical and enzymatic methods.

Authors:  S A Engelholm; M Spang-Thomsen; N Brünner; I Nøhr; L L Vindeløv
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

8.  Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.

Authors:  Katarzyna Szarc vel Szic; Ken Op de Beeck; Dariusz Ratman; An Wouters; Ilse M Beck; Ken Declerck; Karen Heyninck; Erik Fransen; Marc Bracke; Karolien De Bosscher; Filip Lardon; Guy Van Camp; Wim Vanden Berghe
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  The paradoxical functions of EGFR during breast cancer progression.

Authors:  Remah Ali; Michael K Wendt
Journal:  Signal Transduct Target Ther       Date:  2017-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.